What is the share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) today?
The share price of INDRAMEDCO as on 23rd May 2025 is ₹414.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are- Past 1 week: 1.73%
- Past 1 month: -2.69%
- Past 3 months: 4.54%
- Past 6 months: -1.11%
- Past 1 year: 69.36%
- Past 3 years: 609.76%
- Past 5 years: 1015.75%
What are the peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
The peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO) include:What is the dividend yield % of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 1.09.What is the market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹3799.85 Cr as of 23rd May 2025.What is the 52 week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The 52-week high of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹572 and the 52-week low is ₹211.30.What is the PE and PB ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) stock?
The P/E (price-to-earnings) ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 23.60. The P/B (price-to-book) ratio is 7.95.Which sector does Indraprastha Medical Corporation Ltd (INDRAMEDCO) belong to?
Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares?
You can directly buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indraprastha Medical Corporation Ltd
INDRAMEDCO Share Price
414.250.06% (-0.25)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
INDRAMEDCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.60 | 7.95 | 1.09% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.78 | 6.46 | 0.86% |
INDRAMEDCO Analyst Ratings & Forecast
Detailed Forecast 100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
INDRAMEDCO Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
INDRAMEDCO Similar Stocks (Peers)
Compare with peersMAXHEALTH
PE Ratio
103.75
1Y Return
36.97%
Buy Reco %
75.00
APOLLOHOSP
PE Ratio
111.28
1Y Return
18.51%
Buy Reco %
86.21
FORTIS
PE Ratio
70.58
1Y Return
54.10%
Buy Reco %
100.00
PE Ratio
44.33
1Y Return
35.95%
Buy Reco %
66.67
MEDANTA
PE Ratio
66.09
1Y Return
4.51%
Buy Reco %
71.43
INDRAMEDCO Forecasts
INDRAMEDCO Forecast
Price
Revenue
Earnings
INDRAMEDCO Share Price Forecast
2025
Current
₹414.50
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹414.50
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO Company Revenue Forecast
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO
Income
Balance Sheet
Cash Flow
Annual Normal View
INDRAMEDCO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 766.18 | 753.45 | 788.64 | 831.46 | 614.06 | 891.28 | 1,108.70 | 1,261.59 | 1,379.01 | 1,379.01 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,112.09 | 1,112.09 | ||||||||||
| Power & Fuel Cost | 20.91 | 19.26 | 19.70 | 21.16 | 17.18 | 20.56 | 22.74 | 26.01 | ||||||||||||
| Employee Cost | 190.26 | 194.01 | 200.21 | 213.93 | 197.71 | 213.92 | 246.70 | 261.61 | ||||||||||||
| Selling & Administrative Expenses | 76.58 | 72.29 | 78.20 | 83.66 | 186.62 | 292.12 | 407.26 | 462.43 | ||||||||||||
| Operating & Other expenses | 399.17 | 394.31 | 409.28 | 425.63 | 171.60 | 247.26 | 271.27 | 301.29 | ||||||||||||
EBITDA | 79.26 | 73.58 | 81.25 | 87.08 | 40.95 | 117.42 | 160.73 | 210.25 | 266.92 | 266.92 | ||||||||||
| Depreciation/Amortization | 30.53 | 30.68 | 29.75 | 32.97 | 33.32 | 34.94 | 39.27 | 40.08 | 44.33 | 44.33 | ||||||||||
| PBIT | 48.73 | 42.90 | 51.50 | 54.11 | 7.63 | 82.48 | 121.46 | 170.17 | 222.59 | 222.59 | ||||||||||
| Interest & Other Items | 7.91 | 8.90 | 6.87 | 5.92 | 3.34 | 3.41 | 4.28 | 4.06 | 6.27 | 6.27 | ||||||||||
| PBT | 40.82 | 34.00 | 44.63 | 48.19 | 4.29 | 79.07 | 117.18 | 166.11 | 216.32 | 216.32 | ||||||||||
| Taxes & Other Items | 14.57 | 12.90 | 16.21 | 4.57 | 1.96 | 20.45 | 31.03 | 42.15 | 55.33 | 55.33 | ||||||||||
| Net Income | 26.25 | 21.10 | 28.42 | 43.62 | 2.33 | 58.62 | 86.15 | 123.96 | 160.99 | 160.99 | ||||||||||
| EPS | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 17.56 | ||||||||||
| DPS | 1.80 | 1.50 | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | 4.50 | 4.50 | 4.50 | ||||||||||
| Payout ratio | 0.63 | 0.65 | 0.52 | 0.00 | 0.00 | 0.39 | 0.32 | 0.33 | 0.26 | 0.26 |
INDRAMEDCO Company Updates
FY 2014
Annual report
PDFFY 2015
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFINDRAMEDCO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd | 23.60 | 7.95 | 1.09% |
| Max Healthcare Institute Ltd | 103.75 | 13.28 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 111.28 | 13.66 | 0.23% |
| Fortis Healthcare Ltd | 70.58 | 6.39 | 0.14% |
INDRAMEDCO Stock Price Comparison
Compare INDRAMEDCO with any stock or ETFCompare INDRAMEDCO with any stock or ETF
INDRAMEDCO
INDRAMEDCO Shareholdings
INDRAMEDCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDRAMEDCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDRAMEDCO
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Indraprastha Medical Corporation Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.4982% | Percentage of the fund’s portfolio invested in the stock 0.36% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/103 (+12) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.14% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 65/109 (-3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDRAMEDCO stock
Looks like this stock is not in any smallcase yet.
INDRAMEDCO Events
INDRAMEDCO Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDRAMEDCO Upcoming Dividends
No upcoming dividends are available
INDRAMEDCO Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 12, 2019
Final
Final | Div/Share: ₹1.60
Dividend/Share
₹1.60
Ex DateEx Date
Sep 12, 2019
Cash Dividend
Ex DateEx DateSep 12, 2018
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 12, 2018
INDRAMEDCO Stock News & Opinions
Articles & Videos
Corporate
Board of Indraprastha Medical Corporation recommends final dividend
Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 days agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 31.57% in the March 2025 quarter
Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales333.75314.73 6 1356.361244.70 9 OPM %18.3715.39 -18.0115.53 - PBDT66.1851.77 28 260.65206.19 26 PBT55.2741.56 33 216.32166.11 30 NP41.0131.17 32 160.99123.96 30 Powered by Capital Market - Live
6 days agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to discuss results
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Spotlight
ICRA reaffirms ratings of Indraprastha Medical Corp; maintains 'stable' outlook
The agency has also affirmed the company's short term rating at '[ICRA] A1+'. ICRA stated that the rating action factors in Indraprastha Medical Corporation Limited (IMCL)'s established presence and strong market position in the NCR region, its healthy operating metrics and its robust financial profile. The ratings also factor in IMCL's revenue diversification across specialities, including oncology, neurology, cardiology and nephrology, among others. The financial risk profile remains comfortable as reflected by minimal gearing, robust debt protection indicators and a strong liquidity profile. Further, the ratings factor in the strong parentage of Apollo Hospitals Enterprise Limited (AHEL) along with its promoters, holding a 25% stake in IMCL. The entity has significant operational, financial and managerial linkages with AHEL. Apollo Hospitals is among the leading healthcare players, operating one of the largest hospital chains in the country. However, the ratings remain constrained by the geographical and asset concentration risks, as IMCL's operations are concentrated across two hospitals in the National Capital Region (NCR). Like other entities in the sector, IMCL remains exposed to regulatory risks, with previous restrictions imposed by various authorities. The ratings also factor in the competitive pressures and the necessity to retain medical talent in an ever-evolving market. Incorporated in 1988 as a JV between Apollo Hospitals Enterprise (AHEL) and the Delhi Government, Indraprastha Medical Corporation (IMCL) is a 749-bedded, super speciality tertiary care hospital in New Delhi and Noida. The scrip gained 3.09% to currently trade at Rs 415.30 on the BSE. Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to conduct board meeting
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 29.07% in the September 2024 quarter
Net profit of Indraprastha Medical Corporation rose 29.07% to Rs 42.40 crore in the quarter ended September 2024 as against Rs 32.85 crore during the previous quarter ended September 2023. Sales rose 10.35% to Rs 349.82 crore in the quarter ended September 2024 as against Rs 317.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales349.82317.00 10 OPM %18.1915.89 - PBDT68.1053.68 27 PBT56.9343.65 30 NP42.4032.85 29 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation announces board meeting date
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to hold AGM
Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 46.79% in the June 2024 quarter
Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to declare Quarterly Result
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.01%
Over the last 5 years, market share decreased from 2.15% to 1.98%
Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.91%